Overview
Lidiane Filippin practices practicing medicine in Porto Alegre, Brazil.
Filippin is highly rated in 2 conditions, according to our data. Their clinical expertise encompasses Muscle Atrophy, Arthritis, and Rheumatoid Arthritis (RA).
They are actively involved in clinical research, co-authoring 14 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Lidiane I. Filippin
Is Lidiane I. Filippin a top-rated expert for Muscle Atrophy?
MediFind is an objective health platform that identifies experts based on real-world data. Lidiane I. Filippin is classified as an Advanced expert for Muscle Atrophy, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Lidiane I. Filippin participate in research or clinical trials?
Yes. Lidiane I. Filippin has published 14 articles and abstracts on conditions like Muscle Atrophy. You can view a list of Lidiane I. Filippin's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- ArthritisFilippin isAdvanced. Learn about Arthritis.
- Muscle AtrophyFilippin isAdvanced. Learn about Muscle Atrophy.
- Experienced
- Rheumatoid Arthritis (RA)Filippin isExperienced. Learn about Rheumatoid Arthritis (RA).